Mkts

Fulcrum Therapeutics, Inc.

NASDAQ: FULC
$3.70-0.07 (-1.86%)
As of Oct 30, 2:35 PM ET

Key statistics

Day range
3.683.76
52-week range
2.8315.74
Today
Open3.74
Previous close3.70
Volume—
Valuation
Market cap286.88M
P/E ratio—
EPS (TTM)-0.90
Income & risk
Dividend / yield—
Beta2.79
Avg volume1.66M
Discussion

FULC News

Stories mentioning FULC from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development14,08415,41614,29612,98713,40411,71314,63917,261
Sales General & Admin
Total Operating Expenses22,18622,69321,85819,81520,40319,42925,12627,508
Operating Income (Loss)(22,186)(22,693)(21,858)(19,815)(20,403)(19,429)(25,126)52,492
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(18,891)(20,334)(19,595)(17,296)(17,655)(16,568)(21,696)55,409
Earnings Per Share (Basic)(0.25)(322.76)(0.31)(0.28)(0.28)(267.23)(0.35)0.89
Earnings Per Share (Diluted)(0.25)(322.76)(0.31)(0.28)(0.28)(267.23)(0.35)0.87
Weighted Average Shares Outstanding (Basic)76,21563.0062,59762,54462,47962.0062,40962,205
Weighted Average Shares Outstanding (Diluted)76,21563.0062,59762,54462,47962.0062,40963,587

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About FULC

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is a stock listed on the Nasdaq Stock Market under the ticker symbol FULC. It last traded at $3.70 (Oct 30, 2026, 2:35 PM ET), down 1.9% on the day. That gives Fulcrum Therapeutics a market capitalisation of $286.9M.

Over the past 52 weeks FULC has traded between $2.83 and $15.74.

For the quarter ended Mar 31, 2026 it reported a net loss of $18.9M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$18.9M
Dec 31, 2025—-$20.3M
Sep 30, 2025—-$19.6M
Jun 30, 2025—-$17.3M

From Fulcrum Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…